| P2093 | author name string | Hirota Fujiki | |
| | Kazue Imai | |
| | Kei Nakachi | |
| | Masami Suganuma | |
| P2860 | cites work | Combination cancer chemoprevention with green tea extract and sulindac shown in intestinal tumor formation in Min mice | Q32019612 |
| | Green tea and the risk of gastric cancer in Japan | Q32067185 |
| | Cancer prevention with green tea and monitoring by a new biomarker, hnRNP B1. | Q34338150 |
| | A new function of green tea: prevention of lifestyle-related diseases | Q34497493 |
| | Reduced risk of esophageal cancer associated with green tea consumption | Q39401235 |
| | Cancer-preventive effects of drinking green tea among a Japanese population | Q39456794 |
| | Phase I trial of oral green tea extract in adult patients with solid tumors | Q40719425 |
| | Modulation of gene expression by (-)-epigallocatechin gallate in PC-9 cells using a cDNA expression array | Q40785351 |
| | Wide distribution of [3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue | Q48356106 |
| | A case-control study of gastric cancer and diet in northern Kyushu, Japan. | Q55222654 |
| | Two stages of cancer prevention with green tea | Q73133208 |
| | Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention | Q73584176 |
| | Antitumor promoting activity of (−)-epigallocatechin gallate, the main constituent of “Tannin” in green tea | Q104387692 |
| P433 | issue | 1-2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | tea | Q6097 |
| | sulindac | Q963093 |
| P304 | page(s) | 9-13 | |
| P577 | publication date | 2002-12-01 | |
| P1433 | published in | Cancer Letters | Q326372 |
| P1476 | title | Green tea: cancer preventive beverage and/or drug | |
| P478 | volume | 188 | |